Jennifer Hopp, MD
Sports Medicine · Portsmouth, NHNPI 1124312137
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for sports medicine clinicians in NH, where the typical reported total is $1,336.
Across 16 payments — averaging $15.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$41
- Novo Nordisk$36
- Amarin Pharma, Inc.$31
- Si-bone, Inc.$27
- Sanofi Pasteur Inc.$27
- Johnson & Johnson$25
- plus $63 from 3 others
What the payments were for
- Food & beverage$250100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 3 | $41 |
| Novo Nordisk | 3 | $36 |
| Amarin Pharma, Inc. | 2 | $31 |
| Si-bone, Inc. | 1 | $27 |
| Sanofi Pasteur Inc. | 2 | $27 |
| Johnson & Johnson | 1 | $25 |
| Lilly USA, LLC | 2 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
| Amgen | 1 | $15 |
How this compares
$250 in reported general payments places this provider in the 30th percentile of 38 sports medicine providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 63 | $234 |
| Diclofenac Sodium | 24 | $208 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Portsmouth
- Tyler WelchPortsmouth$6K
- Mark CullenPortsmouth$5K
- Jennifer StebbingPortsmouth$167
- John McMahonPortsmouth$22
- Joshua SiegelExeter$438K
- Avnish ClerkExeter$89K
- Neal GoldenbergKeene$38K
- Brendan HigginsConcord$34K
- Jason SimonNashua$9K
- Benjamin ThompsonExeter$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.